Lineage Cell Therapeutics, Inc. (LCTX): 6 insider purchases in the last two years.
| Filed | Insider | Shares | Price | Value | Type |
|---|---|---|---|---|---|
| Mar 12, 2026 | Culley Brian M Director, Officer | 15,000 | $1.63 | $24.4K | no history |
| Jan 28, 2025 | Broadwood Capital Inc TenPercentOwner | 7,894,737 | $0.76 | $6.0M | no history |
| Nov 26, 2024 | Samuel George A. III Officer | 15,000 | $0.60 | $9.0K | no history |
| Nov 26, 2024 | Howe Jill Ann Officer | 15,000 | $0.59 | $8.8K | no history |
| Nov 25, 2024 | Mulroy Michael H. Director | 40,000 | $0.57 | $22.8K | no history |
| Nov 22, 2024 | Culley Brian M Director, Officer | 40,000 | $0.60 | $24.0K | no history |
Open-market purchases from SEC Form 4. "Opportunistic" = this insider trades every year but not on a fixed schedule (Cohen, Malloy & Pomorski); "routine" buys carry little information.
Free account. Know when insiders, famous funds or Congress trade it.